Latest News
Media Releases, News Items & More
FDA Qualifies First Surrogate Endpoint For Use In Osteoporosis Clinical Trials
December 22, 2025
Update On Clinical Trials FDA Qualifies First Surrogate Endpoint For Use In Osteoporosis Clinical Trials December 22, 2025 Osteoporosis Canada is excited to share the US Food and Drug Administration […]
World Health Organization (WHO) publishes article on benchmarks for equitable hip-fracture care and osteoporosis treatment in older people
December 9, 2025
Latest News World Health Organization (WHO) publishes article on benchmarks for equitable hip-fracture care and osteoporosis treatment in older people December 9, 2025 In Canada, one in three hip fracture […]
Memorandum of Understanding between Osteoporosis Canada and the Fragility Fracture Network
December 3, 2025
Latest News Memorandum of Understanding between Osteoporosis Canada and the Fragility Fracture Network December 2, 2025 Osteoporosis Canada has signed a Memorandum of Understanding (MOU) with the Fragility Fracture Network […]
Dr. Earl Bogoch Appointed as Member of the Order of Canada
July 16, 2025
Latest News Dr. Earl Bogoch Appointed as Member of the Order of Canada July 16, 2025 Osteoporosis Canada is pleased to share Dr. Earl Bogoch has been appointed as Member […]
Osteoporosis Canada Becomes HealthPartners Member
May 16, 2025
Latest News Osteoporosis Canada Becomes HealthPartners Member May 16, 2025 In March 2025 it was announced that Osteoporosis Canada was one of three new charities to join the membership of […]
Dr. Lora Giangregorio Named Canada Research Chair
March 19, 2025
Latest News Dr. Lora Giangregorio Named Canada Research Chair March 19, 2025 The University of Waterloo, Kinesiology and Health Sciences Professor Lora Giangregorio has been awarded a Tier 1 Canada […]
Recently launched Apo-Teriparatide Injection now as a listed benefit in Ontario
February 20, 2025
Latest News Recently launched Apo-Teriparatide Injection now as a listed benefit in Ontario February 20, 2025 Apo-Teriparatide Injection ™ is a generic alternative to Forteo®. Osteoporosis pharmacologic therapies are classified […]
2024 Gideon A. Rodan Excellence in Mentorship Award
August 16, 2024
Latest News 2024 Gideon A. Rodan Excellence in Mentorship Award Angela Cheung, M.D., Ph.D. is the recipient of the 2024 Gideon A. Rodan Excellence in Mentorship Award which is given […]
Sandoz receives Health Canada approval for Jubbonti®, first and only denosumab biosimilar for treatment of osteoporosis.
May 31, 2024
Latest News Sandoz receives Health Canada approval for Jubbonti®, first and only denosumab biosimilar for treatment of osteoporosis. May 31, 2024 Health Canada has provided authorization to market Jubbonti® (denosumab […]